AC
Aphelion Capital
Healthcare Venture CapitalMill Valley, United StatesSee on the mapaphelioncapital.net
Health specialist
healthcaremedical devicesdigital health
Aphelion Capital is a healthcare venture capital firm investing in early- and mid-stage medical device and digital health companies. It focuses on products and services that improve patient outcomes at the same or lower cost to the healthcare system.
- 2
- Portfolio companies on reccy
- 1
- Hiring now
- 1
- Open roles in the portfolio
- Mar 2024
- Latest portfolio round
Hiring now in the portfolio1
Apply on each company's sitePortfolio on reccy2
From company funding recordsCompanyRound backedOpen roles
Their companies, round by round
From company funding records- PhagenesisManchester, UK
Neurorehabilitation and assistive tech
- Mar 2024Series D · $42MLed
- Jun 2022Accelerator/Incubator
- May 2013Series B · $17M
- May 2012Grant
- Oct 2011Series B · $9.3M
- Sep 2010Series A · $3.1M
- ZetoRaleigh, NC
EEG and neural monitoring
- Jan 2025Series B · $31M
- Mar 2020Series A · $7.3M
- UndatedSeed · $4M
- UndatedSeries A
- UndatedVenture Round
Rounds marked Led list Aphelion Capital as a lead investor; the rest are the company's other funding.
Recent rounds in the portfolio
- Mar 2024
Phagenesis · Series D $42MLead
With Sectoral Asset Management, EQT Life Sciences, British Patient Capital, Northern Gritstone
Portfolio in the news
From the Cortex · last 12 months- Oct 2026